Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Exclusive: Campaign group calls on institutional shareholders to vote against re-election of bosses overseeing net zero row-back Bank chairs who water down their lenders’ climate commitments this year ...
Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Under Armour reportedly shifted close to 500,000 Instagram followers from Curry Brand to UA basketball. In November 2025, Under Armour and Stephen Curry announced the end of their 13-year partnership.
SA Treasurer Tom Koutsantonis has released a recording of Shadow Water Minister Nicola Centofanti announcing a backtrack of the Opposition's major $495m cost of living policy at an industry event. The ...
If Americans during President Donald Trump’s first term were exhausted by his “controversy and chaos,” they now appear to be similarly distressed by his “backtracking and blowing things up,” according ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results